This article and associated images are based on a poster originally authored by Marisa Amato and presented at ELRIG Drug Discovery 2025 in affiliation with Singleron Biotechnologies GmbH. This poster ...
Introducing a new RNA-seq platform for intracellular multimodal profiling that could transform cancer research and ...
Single-cell RNA-seq (scRNA-seq) has spent the past decade maturing into a foundational technology. Over that time, the technology has both laid the foundation for building cell atlases and allowed ...
While bulk sequencing quickly became the preferred method, scRNA-seq has increased in popularity in the last decade. In 2015, just 6 % of RNA-seq papers used single-cell methodologies. By 2025, the ...
RNA is the means of translating the genetic code embedded in DNA into proteins, which serve as enzymes, transporters, ...
Out of touch: Understanding the frequency and trajectory of chemotherapy-induced neuropathy peripheral (CIPN) in breast cancer survivors. Incidence of ocular toxicities in patients with ...
A new AI-driven framework enables highly accurate prediction of RNA splicing and isoform usage for therapeutic applications.
A new AI-based system combines genomic sequences and RNA-binding protein profiles to model complex RNA splicing patterns ...
Key growth drivers include technological advancements, reduced sequencing costs, and increased interest from academia and pharmaceuticalsDublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Single Cell ...
Genome-wide association studies have linked thousands of genetic variants to disease, yet most remain disconnected from drug-relevant biology. Neville Sanjana, Professor at New York University and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results